BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose.

The company was founded as a spin-off from the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation, NIH and DOD contracts, BlueWillow’s technology has been advanced significantly in recent years yielding several therapies in development.

Biotechnology

BlueWillow Biologics

BlueWillow Biologics' headquarters in Ann Arbor, MI, United States

Chad Costley

Lawrence Black

Kishna Kalicharran

George Arida

Hugo Braun

Roger D’Orazio

David M. Stout

Phil Wilmington

Research and Development

BlueWillow Biologics

Org chart

Board & advisors

Teams

Research and Development

Offices

Similar companies